Adiponectin and Colorectal Cancer
Author Information
Author(s): Fujisawa T, Endo H, Tomimoto A, Sugiyama M, Takahashi H, Saito S, Inamori M, Nakajima N, Watanabe M, Kubota N, Yamauchi T, Kadowaki T, Wada K, Nakagama H, Nakajima A
Primary Institution: Yokohama City University School of Medicine
Hypothesis
The plasma level of adiponectin may be related to the risk of colorectal cancer.
Conclusion
Adiponectin suppresses colonic epithelial proliferation via inhibition of the mammalian target of the rapamycin pathway under a high-fat diet.
Supporting Evidence
- Adiponectin-deficient mice had significantly more colon polyps than wild-type mice on a high-fat diet.
- Cell proliferation in the colonic epithelium was higher in adiponectin-deficient mice compared to wild-type mice on a high-fat diet.
- The mTOR pathway was activated in the colon epithelium of adiponectin-deficient mice.
Takeaway
Adiponectin helps prevent colon cancer, especially when eating a lot of fat. Without it, the risk of cancer goes up.
Methodology
The study used gene-deficient mice to investigate the effects of adiponectin deficiency on colon cancer development.
Limitations
The study primarily used animal models, which may not fully replicate human conditions.
Participant Demographics
Mice were used in the study, specifically adiponectin-deficient and wild-type mice.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website